AstraZeneca stock after-hours at EUR 141.75: minus 1.05 percent versus prior close
Published on 10/01/2026 at 17:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
AstraZeneca stock was at EUR 141.75 after-hours at 5:41 p.m. CEST on October 1, 2026, down 1.05 percent versus the Lang & Schwarz prior close of EUR 143.25.
Trading day in Frankfurt
The Lang & Schwarz quote showed a bid of EUR 141.55 and an ask of EUR 141.95. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of AstraZeneca stock.
Alexion presents rare-disease data
In a September 24 release, Alexion, AstraZeneca Rare Disease, said it would present data across 15 presentations at the American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and the Myasthenia Gravis Foundation of America Scientific Session, held September 29 through October 2, 2026. The program included new 52-week data from the PREVAIL Phase III trial of gefurulimab in adults with generalized myasthenia gravis. AstraZeneca said the release included additional analyses from the PREVAIL trial through week 26.
